The Evolution of Glioblastoma Multiforme Market and Emerging Therapies

added blog Health

2025-03-27 07:12:04

Introduction Glioblastoma multiforme (GBM) is one of the most aggressive and lethal brain cancers, characterized by rapid progression and poor survival rates. Despite existing treatment options, the glioblastoma multiforme survival rate remains alarmingly low, with most patients living only about 12 to 15 months after diagnosis. The lack of effective long-term treatments has driven...

0 Komen 0 Perkongsian 714 Views 0 review